Regulatory training on transitional trials in CTIS with open question and answers session

13 February 2024

EMA has organized in the series of the CTIS Bitesize Talk an event related to the transitional trial in CTIS Thursday, 29 February 2024, 16:30 (CET) - 18:00 (CET).

CTIS is the business tool of the EU Clinical Trials Regulation (Regulation (EU) No 536/2014) and it acts as a single entry point for clinical trial authorisation and supervision in the European Union (EU) and the European Economic Area (EEA).

This bitesize talk on CTIS provides an opportunity for sponsors to learn how to create and submit transitional trials in Clinical Trials Information System (CTIS). Sponsors will also have the opportunity to ask questions on this CTIS topic before and during the event.

The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.

CTIS Bitesize Talk: How to submit a transitional trial in CTIS | European Medicines Agency (europa.eu)